Latest News about Michael Spector
Recent news which mentions Michael Spector
Caelum Biosciences to be acquired by division of AstraZeneca in $150M deal
September 30, 2021
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>